Relapsing encephalopathy in a patient with alpha-methylacyl-CoA racemase deficiency

S. A. Thompson, J. Calvin, S. Hogg, S. Ferdinandusse, R. J. A. Wanders, R. A. Barker

Research output: Contribution to journalArticleAcademicpeer-review

33 Citations (Scopus)

Abstract

Alpha-methylacyl-CoA racemase (AMACR) deficiency is a rare disorder of fatty acid metabolism which has recently been described in three adult cases. We have identified a further patient with clinical features of a relapsing encephalopathy, seizures and cognitive decline over a 40 year period. Biochemical studies revealed grossly elevated plasma pristanic acid levels, and a deficiency of AMACR in skin fibroblasts. Sequence analysis of AMACR cDNA identified a homozygous point mutation (c154T>C). This case adds to the phenotypic variation seen in this peroxisomal disorder and highlights the importance of screening for plasma pristanic acid levels in patients with unexplained relapsing encephalopathies
Original languageEnglish
Pages (from-to)448-450
JournalJournal of neurology, neurosurgery, and psychiatry
Volume79
Issue number4
DOIs
Publication statusPublished - 2008

Cite this